Prior view $19.20-$20.30, consensus $19.59. Backs FY24 revenue view $4B-$4.1B, consensus $4.04B.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- JAZZ Earnings this Week: How Will it Perform?
- Wells downgrades Zymeworks with zanidatamab approval priced in
- Jazz Pharmaceuticals’ Xywav shows efficacy in narcolepsy, idiopathic hypersomnia
- Court ruling removes ‘last binary risk’ for Avadel, says H.C. Wainwright
- Avadel Pharmaceuticals price target raised to $30 from $29 at Oppenheimer